News: Home Page Latest News

Next Page »

New Insights on Postpartum Breast Cancer

Friday, October 31st, 2014

A new study explaining the cellular activity that leads to breast tumor metastasis among women who have recently given birth may offer new treatment direction for postpartum breast cancer.

Indiana Couple Supports Melanoma Research

Thursday, October 16th, 2014

Vanderbilt-Ingram Cancer Center (VICC) melanoma patient Gerald (Jerry) Schreiber and wife Phyllis organized and hosted the first annual Melanoma Research Golf Classic in Evansville, Indiana. The golf scramble raised $19,000 for VICC melanoma research spearheaded by Igor Puzanov, M.D., MSCI, associate professor of Medicine and director of Melanoma Clinical Research.

Rising Tobacco Epidemic in Asia

Tuesday, June 10th, 2014

A new study estimates that tobacco smoking has been linked to approximately 2 million deaths among adult men and women in Asia in recent years and predicts a rising death toll. The study, published in PLOS Medicine, was led by Wei Zheng, M.D., Ph.D., MPH, professor of Medicine and director of the Vanderbilt Epidemiology Center, […]

Martell Foundation Honors VICC Leaders

Monday, March 24th, 2014

Scott Hiebert, Ph.D., associate director of Basic Research at Vanderbilt-Ingram Cancer Center, was celebrated for his contributions to cancer research during the 6th Annual Nashville Honors Gala benefiting the T. J. Martell Foundation. This year’s event at Nashville’s Omni Hotel honored five Nashville community leaders who work diligently to make a difference in the community, […]

VICC Offers Lung Cancer Screens

Thursday, February 27th, 2014

Vanderbilt-Ingram Cancer Center has launched a new lung cancer screening program to provide low-dose CT scans for patients at high risk for the deadly disease. Current or former smokers ages 55 to 74 who have a history of 30 or more pack years of smoking are eligible for the scans. A pack year is defined […]

Breast SPORE Grant Renewed Again

Wednesday, November 27th, 2013

Vanderbilt-Ingram Cancer Center’s Breast Specialized Program of Research Excellence (SPORE) has been awarded a third round of funding from the National Cancer Institute (NCI). The SPORE grant renewal will provide more than $11.3 million in funding support over the next five years for breast cancer research. “It is becoming uncommon for a cancer center to […]

VICC & Maury Regional Team Up for Radiation Oncology Spring Hill

Friday, June 21st, 2013

By Dagny Stuart Maury Regional Medical Center (MRMC) and Vanderbilt-Ingram Cancer Center (VICC) have joined forces to open a new radiation oncology treatment center for cancer patients in Spring Hill, Tenn. The radiation oncology facility, which has been named the Vanderbilt-Ingram Cancer Center at Maury Regional Spring Hill, is located at 1003 Reserve Boulevard near […]

Regional variations in benign lung disease

Thursday, May 30th, 2013

By Dagny Stuart A study led by Vanderbilt University Medical Center investigators found that rates of benign lung disease diagnosis varied widely by state following surgery for lung cancer. The results could have an impact on clinical guidelines and health policy for lung cancer screening. The study was presented by Stephen A. Deppen, M.A., M.S., […]

HER2 May Impact Lung Cancer Therapy

Friday, September 21st, 2012

Overcoming therapeutic resistance that inevitably develops is one of the major challenges in treating lung cancer. Non-small cell lung cancers that harbor mutations in the epidermal growth factor receptor (EGFR) are initially responsive to targeted therapies known as EGFR tyrosine kinase inhibitors (TKIs). However, most patients eventually develop resistance to these therapies. One such targeted […]

Study Reveals Racial Disparities in Prostate Cancer Care

Thursday, August 23rd, 2012

A study led by investigators from Vanderbilt-Ingram Cancer Center (VICC), Nashville, Tenn., finds that black men with prostate cancer receive lower quality surgical care than white men. The racial differences persist even when controlling for factors such as the year of surgery, age, comorbidities and insurance status. Daniel Barocas, M.D., MPH, assistant professor of Urologic […]